ADAM-9 modulators

Details for Australian Patent Application No. 2006210589 (hide)

Owner MacroGenics West, Inc.

Inventors Loo, Deryk; Mather, Jennie

Agent Fisher Adams Kelly

Pub. Number AU-B-2006210589

PCT Pub. Number WO2006/084075

Priority 60/649,787 02.02.05 US

Filing date 2 February 2006

Wipo publication date 10 August 2006

Acceptance publication date 8 December 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/084075 Priority application(s): WO2006/084075

9 December 2010 Alteration of Name

  The name of the applicant has been altered to MacroGenics West, Inc.

8 December 2011 Application Accepted

  Published as AU-B-2006210589

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210590-Vaso-occlusive devices including nonbiodegradable biomaterials

2006210587-Aqueous gel formulations containing 1-(2-methylpropyl)-1H-imidazo[4,5-c][1, 5]naphthyridin-4-amine